Automated Clinical Pathway for Inflammatory Bowel Disease Care

NANot yet recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Inflammatory Bowel DiseaseInflammatory Bowel Disease (IBD)
Interventions
OTHER

Electronic medical record-based care pathway

Participants will undergo initial automated risk stratification to direct tailored follow-up intervals. If exceeding the maximum time interval, participants in the intervention arm will be contacted by scheduling personnel using a standardized protocol to schedule a follow-up visit. In contrast, patients in the control arm who are overdue will not be made known to any staff and will not be proactively contacted, instead continuing to be managed according to standard of care. To maximize generalizability and understanding among staff and patients, risk stratification will be based on inflammatory bowel disease medication use.

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT07167836 - Automated Clinical Pathway for Inflammatory Bowel Disease Care | Biotech Hunter | Biotech Hunter